786686-79-1 Usage
Description
OLANZAPINE-METHYL-D3 is a deuterated form of Olanzapine, a pharmaceutical compound that acts as a serotonin (5-HT2) and dopamine (D1/D2) receptor antagonist with anticholinergic activity. It is primarily used as an antipsychotic medication. OLANZAPINE-METHYL-D3 is characterized by its yellow to brown solid appearance.
Uses
Used in Pharmaceutical Industry:
OLANZAPINE-METHYL-D3 is used as a research tool for studying the binding and interaction of Olanzapine with its target receptors. The deuteration of the molecule allows for enhanced stability and specificity in various analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy.
Used in Drug Development:
OLANZAPINE-METHYL-D3 serves as a valuable compound in the development of new antipsychotic drugs. Its deuterated nature provides insights into the structure-activity relationship of Olanzapine and its analogs, aiding in the design and optimization of more effective and safer medications for the treatment of psychiatric disorders.
Used in Neuroscientific Research:
OLANZAPINE-METHYL-D3 is employed in neuroscientific research to investigate the mechanisms of action of antipsychotic drugs on the central nervous system. Its use helps researchers understand the role of serotonin and dopamine receptors in the pathophysiology of psychiatric disorders and the therapeutic effects of antipsychotic medications.
Check Digit Verification of cas no
The CAS Registry Mumber 786686-79-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,6,6,8 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 786686-79:
(8*7)+(7*8)+(6*6)+(5*6)+(4*8)+(3*6)+(2*7)+(1*9)=251
251 % 10 = 1
So 786686-79-1 is a valid CAS Registry Number.
InChI:InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3/i2D3
786686-79-1Relevant articles and documents
THIENOBENZODIAZEPINE MODULATORS OF D1 RECEPTOR, D2 RECEPTOR, AND/OR 5-HT2 RECEPTOR
-
Page/Page column 16, (2010/11/03)
The present invention relates to new thienobenzodiazepine modulators of D1 receptors, D2 receptors, and/or 5-HT2 receptors, pharmaceutical compositions thereof, and methods of use thereof.
